About the group
Our main research aim is to understand how NK cells interact with and kill cancer cells. We have a particular focus on how NK cells utilizes extracellular vesicles for this purpose, and cover discoveries of new mechanistic biological insights with pre-clinical tests to develop new therapies.
Projects
- Developing NK-cell derived extracellular vesicles for cancer therapy
- Developmental and functional characterization of NK cell subsets and ILCs in different tissues in the rat, and their regulation of inflammation.
- Understanding the complex crosstalk between microbiota and prebiotics, their metabolites, and the effects on the gut immune system.
- Exploiting plasma-derived extracellular vesicles as biomarkers for disease.
Cooperation
- Senior Researcher Rachel Crossland, Newcastle University, UK
- Professor Martha Enger, University of Bergen
- Professor Erik Dissen, IMB, University of Oslo
- Førsteamanuensis Kari Tvete Inngjerdingen, University of Oslo
- Professor Helle Wangensten, University of Oslo
- Fridtjof Lund-Johansen, Dept of Immunology, Oslo University Hospital
- Senior Researcher Jørgen Wesche, Oslo University Hospital